Jonathan McKinnon Collins

Meet Jonathan McKinnon Collins- an accomplished inventor with an impressive portfolio of 21 patents. Collins operates from Charlotte, North Carolina, where he works for CEM Corporation- a leading science and technology company.

Collins' latest inventions are proof of his strong acumen in the field of peptide synthesis. His first invention is a solvent system for solid-phase peptide synthesis, which combines a morpholine-based compound and an alkoxybenzene-based compound to form a solvent compatible with both polystyrene and PEG resins.

The solvent system can produce purity yields comparable to conventional solvents like DMF, DMA, and/or NMP; yet, it maintains the advantage of being more compatible with various resin types.

Collins' most recent patent is an improved method of coupling amino acids into peptides or peptidomimetics. This method activates and couples amino acids into peptides or peptidomimetics using excess carbodiimide in an amount greater than 1 equivalent when compared to amino acid. Additionally, the coupling process is carried out at a temperature greater than 30°C with an activator additive present, all in the same vessel.

Collins' inventions have been crucial to the development of the peptide synthesis industry. His works have made a significant impact on the efficiency and ease of peptide synthesis, impacting research and development across multiple fields.

Collins' colleagues, Michael John Collins and Joseph Joshua Lambert, also play an integral role at CEM Corporation. Michael John Collins is a Senior Vice President, Product Management, and R&D, while Joseph Joshua Lambert is a Director of Sales, Americas. Together, they work with Jonathan to drive innovation within the company.

Jonathan Mckinnon Collins has made noteworthy strides in the field of peptide synthesis, and his patents will undoubtedly continue to impact the industry positively.